Overview
- Determine clinical characteristics of parkinsonian patients in various stages of disease;
- Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.
- Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Eligibility
Inclusion Criteria:
- Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
- Age: 18-80 years;
- Signature of informed consent to participate in this study
Exclusion criteria.
- Women pregnant
- Inflammatory or autoimmune diseases


